NVWM, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NVWM, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$31,844
-11.3%
2,724
+1.9%
0.01%
-16.7%
Q2 2023$35,912
-18.2%
2,672
+0.9%
0.01%
-20.0%
Q1 2023$43,9202,6490.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 159,791$1,8685.34%
Opaleye Management Inc. 1,205,000$14,086,4504.58%
GABLES CAPITAL MANAGEMENT INC. 431,955$5,049,5543.51%
JW Asset Management, LLC 563,392$6,586,0522.85%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,192,000$95,764,4802.11%
Seaport Global Advisors, LLC 45,941$537,0501.61%
Capital Impact Advisors, LLC 67,067$784,0131.31%
Ikarian Capital, LLC 505,862$5,913,5270.71%
MOODY ALDRICH PARTNERS LLC 273,512$3,197,3550.61%
Paradiem, LLC 166,905$1,951,1190.59%
View complete list of CATALYST PHARMACEUTICALS INC shareholders